CR20130401A - INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT - Google Patents
INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENTInfo
- Publication number
- CR20130401A CR20130401A CR20130401A CR20130401A CR20130401A CR 20130401 A CR20130401 A CR 20130401A CR 20130401 A CR20130401 A CR 20130401A CR 20130401 A CR20130401 A CR 20130401A CR 20130401 A CR20130401 A CR 20130401A
- Authority
- CR
- Costa Rica
- Prior art keywords
- nsaid
- inflammatory
- mastitis
- antibiotic
- injectable compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Abstract
Un compuesto inyectable cuando se utiliza para el tratamiento de una infección microbiana en una glándula mamaria de un animal, en el que el compuesto incluye a) un fármaco antinflamatorio no esteroide (AINE)An injectable compound when used for the treatment of a microbial infection in an mammary gland of an animal, in which the compound includes a) a non-steroidal anti-inflammatory drug (NSAID)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ588686A NZ588686A (en) | 2011-01-20 | 2011-01-20 | Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland |
Publications (1)
Publication Number | Publication Date |
---|---|
CR20130401A true CR20130401A (en) | 2014-02-04 |
Family
ID=46515931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR20130401A CR20130401A (en) | 2011-01-20 | 2013-08-19 | INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT |
Country Status (15)
Country | Link |
---|---|
KR (1) | KR101905173B1 (en) |
CN (1) | CN103327984B (en) |
AU (1) | AU2012207698A1 (en) |
BR (1) | BR112013018557B1 (en) |
CL (1) | CL2013002086A1 (en) |
CO (1) | CO6801732A2 (en) |
CR (1) | CR20130401A (en) |
GT (1) | GT201300182A (en) |
IL (1) | IL227540A (en) |
MX (1) | MX353876B (en) |
NI (1) | NI201300063A (en) |
NZ (1) | NZ588686A (en) |
PE (1) | PE20140035A1 (en) |
WO (1) | WO2012099479A1 (en) |
ZA (1) | ZA201305780B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2995297A1 (en) * | 2014-09-09 | 2016-03-16 | Ceva Sante Animale | Parenteral compositions and uses thereof |
AR102172A1 (en) | 2015-10-05 | 2017-02-08 | Química Luar S R L | A BACTERICIDE AND VIRUCIDE PHARMACEUTICAL COMPOSITION |
CN105663037A (en) * | 2016-01-27 | 2016-06-15 | 成都乾坤动物药业有限公司 | Amoxicillin solution as well as preparation method and application thereof |
CN112472667B (en) * | 2019-08-23 | 2022-11-15 | 北京欧博方医药科技有限公司 | Retxib long-acting injection and preparation method and application thereof |
CN111035614B (en) * | 2019-12-20 | 2024-02-02 | 北京喜禽药业有限公司 | High-content terramycin injection and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6787568B1 (en) | 2000-11-27 | 2004-09-07 | Phoenix Scientific, Inc. | Antibiotic/analgesic formulation and a method of making this formulation |
CN1297319C (en) * | 2003-09-22 | 2007-01-31 | 王玉万 | Preparing pharmaceutics of medication containing antimicrobials by using silicone oil as medium |
EP1677781A4 (en) | 2003-10-29 | 2008-11-19 | Idexx Lab Inc | Salts of pharmacologically active compounds |
DE102004025324A1 (en) * | 2004-05-19 | 2005-12-08 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation for veterinary medicine, process for their preparation and their use |
-
2011
- 2011-01-20 NZ NZ588686A patent/NZ588686A/en unknown
-
2012
- 2012-01-20 WO PCT/NZ2012/000003 patent/WO2012099479A1/en active Application Filing
- 2012-01-20 AU AU2012207698A patent/AU2012207698A1/en not_active Abandoned
- 2012-01-20 KR KR1020137021988A patent/KR101905173B1/en active IP Right Grant
- 2012-01-20 PE PE2013001576A patent/PE20140035A1/en not_active Application Discontinuation
- 2012-01-20 BR BR112013018557-0A patent/BR112013018557B1/en active IP Right Grant
- 2012-01-20 MX MX2013008407A patent/MX353876B/en active IP Right Grant
- 2012-01-20 CN CN201280005989.4A patent/CN103327984B/en active Active
-
2013
- 2013-07-17 NI NI201300063A patent/NI201300063A/en unknown
- 2013-07-17 GT GT201300182A patent/GT201300182A/en unknown
- 2013-07-18 IL IL227540A patent/IL227540A/en not_active IP Right Cessation
- 2013-07-19 CL CL2013002086A patent/CL2013002086A1/en unknown
- 2013-07-31 ZA ZA2013/05780A patent/ZA201305780B/en unknown
- 2013-08-05 CO CO13186092A patent/CO6801732A2/en unknown
- 2013-08-19 CR CR20130401A patent/CR20130401A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2012099479A1 (en) | 2012-07-26 |
NI201300063A (en) | 2014-05-23 |
GT201300182A (en) | 2014-07-28 |
MX2013008407A (en) | 2013-09-26 |
AU2012207698A1 (en) | 2013-04-18 |
KR101905173B1 (en) | 2018-11-28 |
IL227540A (en) | 2017-12-31 |
IL227540A0 (en) | 2013-09-30 |
MX353876B (en) | 2018-02-01 |
PE20140035A1 (en) | 2014-02-16 |
CO6801732A2 (en) | 2013-11-29 |
KR20140012646A (en) | 2014-02-03 |
NZ588686A (en) | 2013-07-26 |
BR112013018557B1 (en) | 2021-11-03 |
BR112013018557A2 (en) | 2016-11-22 |
CN103327984B (en) | 2016-08-17 |
ZA201305780B (en) | 2014-04-30 |
CL2013002086A1 (en) | 2014-07-25 |
CN103327984A (en) | 2013-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008000418A1 (en) | Use of an il-23 antagonist for the treatment of a fungal infection. | |
BR112014000665A2 (en) | compound, use thereof, pharmaceutical composition, antimicrobial agent, and method for preventing or treating a bacterial infection | |
CY1118250T1 (en) | CERTAIN TRIAZOLOPYRAZINS, THEIR COMPOSITIONS AND METHODS FOR USE | |
CL2011001389A1 (en) | Isoxazoline derivative compounds; composition comprising one of the compounds; and use of the compounds in parasite control. | |
CR20140231A (en) | ACETIC BENZOTIAZOL-6-IL ACID DERIVATIVES AND THEIR USE TO TREAT AN HIV INFECTION | |
CR20120418A (en) | VIRUS FLAVIVIRIDAE INHIBITORS | |
CL2009000426A1 (en) | Compounds derived from carbocyclyl / heterocyclyl-pyridin-2-yl-urea, bacterial topoisomerase iv inhibitors; pharmaceutical composition; and its use for the treatment of bacterial infections | |
EA201000775A1 (en) | BETA LACTAMASE INHIBITORS | |
CL2013003287A1 (en) | Compounds derived from 5-trifluoromethyl-4,5-dihydro-isoxazole; intermediate compounds; preparation procedure; pharmaceutical compositions comprising them; and use in the treatment of a parasite infestation in animals. | |
CL2015002755A1 (en) | Antibiotic compositions of ceftolozano. | |
CR11626A (en) | BETA-LACTAMASA INHIBITORS | |
CR20130401A (en) | INJECTABLE COMPOSITIONS FOR MASTITIS THAT INCLUDES A NON-STEROID ANTI-INFLAMMATORY (NSAID) AND AN ANTIBIOTIC IN A NON-WATER SOLVENT | |
CL2015002762A1 (en) | Antimicrobial compositions of polyamide and treatment of mastitis | |
CL2012002716A1 (en) | Use of a dgat1 inhibitor compound because it is useful in the prevention, delay of progress or treatment of a disease or condition selected from chylomicronemia, familial chylomicronemia syndrome and type v hyperlipoproteinemia; a compound derived from substituted heteroaryl; pharmaceutical composition | |
BR112014025041B8 (en) | PHARMACEUTICAL COMPOSITION | |
UY31788A (en) | SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE | |
CL2011000258A1 (en) | Compounds derived from phenylamino-isonicotinamide; mek inhibitors; Pharmaceutical composition and use for the treatment of hyperproliferative diseases such as cancer and inflammation. | |
CL2015002253A1 (en) | Pharmaceutical compositions for the treatment of helicobacter pylori. | |
CL2011000165A1 (en) | Compounds derived from indolinones; pharmaceutical composition comprising said compound; and use of the compound for the treatment and / or prevention of cancer, infections, inflammatory and autoimmune diseases. | |
CL2008001728A1 (en) | Compounds derived from indolinones; pharmaceutical composition comprising said compound; and use of the compound for the treatment of cancer, infections, inflammatory and autoimmune diseases. | |
PE20150167A1 (en) | (R) -NIFURATEL, ITS USE FOR THE TREATMENT OF INFECTIONS AND SYNTHESIS OF (R) AND (S) -NIFURATEL | |
CL2012003341A1 (en) | Pharmaceutical composition for oral administration comprising bendamustine or an ester, a salt or a solvate thereof, and an excipient which is a non-ionic and hydrophilic surfactant; pharmaceutical combination; and its use for the treatment of chronic lymphocytic leukemia and multiple myeloma, among other diseases. | |
BRPI0909211B8 (en) | oral tablet-form formulation of tetracycline compounds | |
CL2012001159A1 (en) | Composition comprising an alpha-1-proteinase inhibitor (api), and at least one amino acid; kit comprising said composition that is used as a pharmaceutical composition suitable for intravenous administration. | |
CL2009000294A1 (en) | Compounds derived from aryl methylidene heterocycles; pharmaceutical composition comprising them; and use in the treatment of neuropathic pain and inflammation. |